FDA Drug recall D-0074-2018
Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only
- FDA Drug
- Class III
- terminated
- Published 2017-11-22
On 2017-11-22 the FDA classified a Class III recall of Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only by Amerisource Health Services, citing failed Stability Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0074-2018 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2017-08-29 |
| Published | 2017-11-22 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Amerisource Health Services |
| Distribution | US |
Product
Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only. Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-390-01
Reason
Failed Stability Specifications
Identifiers
| code_info | Lot #:167194; Exp. 12/31/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0074-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.